TELIX PHARMACEUTIC earnings per share and revenue

TLX1/N earnings per share for the last semiannual are 2.27 MXN whereas the estimation was 1.89 MXN which accounts for 20.00% surprise. Company revenue for the same period amounts to 5.41 B MXN despite the estimated figure of 2.81 B MXN. Estimated earnings per share for the next semiannual are 3.60 MXN, and revenue is expected to reach 6.96 B MXN. Also watch annual changes over time to get a bigger picture of TLX1/N earnings per share and revenue dynamics.